Accession Number:



FRET Imaging Trackable Long Circulating Biodegradable Nanomedicines for Ovarian Cancer Therapy

Descriptive Note:

Technical Report,01 Sep 2013,31 Aug 2015

Corporate Author:

University of Utah Salt Lake City United States

Personal Author(s):

Report Date:


Pagination or Media Count:



The major goal of the proposed project is to develop a novel FRET imaging strategy, which permits visualizing the biodegradation of copolymer-drug conjugates at the body, tissue and cell levels in real time. The information will initiate the understanding of in vivo behavior of biodegradable polymers and support the design of highly efficient drug delivery systems. In the first year of the project we have synthesized numerous FRET trackable biodegradable N-2-hydroxypropylmethacrylamide HPMA copolymer conjugates that were labeled with Cy3andor Cy5, conjugates that contained epirubicin and performed click reactions for chain extension to manipulate their molecular weight. The conjugates were characterized by physicochemical methods and in vitro using human ovarian carcinoma cells. FRET technique was used to investigate the conjugates at cellular level. We achieved correlation of the FRET signal on one hand with the level of cathepsin B expression and with the intracellular degradation of the conjugates on the other hand. In fluorescence spectrophotometry experiments we have demonstrated a quantitative correlation between the FRET signal and the degradation of the HPMA copolymer conjugates. Thus our hypothesis that FRET imaging is suitable for the determination of the degradation and fate of backbone degradable HPMA copolymer conjugates has been validated at the cellular level.

Subject Categories:

Distribution Statement: